Home › Adenoviridae Infections
Adenoviridae Infections clinical trials recruiting in the U.S.
16 studies for Adenoviridae Infections are recruiting participants at sites across the United States.
Cities with the most studies
- Columbus, OH5 studies
- Cincinnati, OH4 studies
- Washington, DC4 studies
- New York City, NY3 studies
- Milwaukee, WI3 studies
By state
- California4 studies
- Maryland4 studies
- New York4 studies
- Ohio7 studies
- Tennessee3 studies
- Wisconsin3 studies
Recently updated studies
The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise
RecruitingObservational study
Ages 2 to 100 · All sexes · Updated Sep 28, 2026 · NCT01011712Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT
RecruitingEarly phase 1Healthy volunteers welcome
Ages 1 to 85 · All sexes · Updated Sep 24, 2026 · NCT03665675Viral Infections in Healthy and Immunocompromised Hosts
RecruitingObservational studyHealthy volunteers welcome
6 Months – 120 Years · All sexes · Updated Sep 14, 2026 · NCT01306084Phase 3 Randomized Trial for Refractory ADV or CMV Infection With Family Matched CTLs and Standard of Care (SOC) vs SOC Alone
RecruitingPhase 3
1 Day – 30 Years · All sexes · Updated Sep 11, 2026 · NCT07225972Donor-Derived Viral Specific T-cells (VSTs)
RecruitingPhase 1/2
4 Weeks · All sexes · Updated Sep 4, 2026 · NCT02048332Third Party Viral Specific T-cells (VSTs)
RecruitingPhase 2
2 Days · All sexes · Updated Sep 4, 2026 · NCT02532452A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 27, 2026 · NCT07544589A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT
RecruitingPhase 3
2 Months · All sexes · Updated Aug 10, 2026 · NCT07387367R-MVST Cells for Treatment of Viral Infections in Children and Young Adults
RecruitingPhase 1
3 Months – 26 Years · All sexes · Updated Jul 30, 2026 · NCT06926894TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
RecruitingPhase 1
All ages · All sexes · Updated Jun 11, 2026 · NCT04013802R-MVST Cells for Treatment of Viral Infections
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT05183490Safety and Immunogenicity of Ad4-HIV Envelope Vaccine Vectors in Healthy Volunteers
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Apr 21, 2026 · NCT03878121Haplo-identical Viral-Specific T-cells for Treatment of Cytomegalovirus and Adenovirus Infections After Hematopoietic Cell Transplantation
RecruitingPhase 2
Up to age 18 · All sexes · Updated Feb 23, 2026 · NCT05664126Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity
RecruitingPhase 1/2
1 Month – 65 Years · All sexes · Updated Aug 14, 2025 · NCT06909110Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection
RecruitingPhase 2
1 Month – 79 Years · All sexes · Updated Aug 8, 2025 · NCT03266627Pilot Study of Haploidentical Donor Adenovirus Specific T-lymphocytes to Treat Refractory Adenovirus Infections
RecruitingPhase 1/2
Up to age 60 · All sexes · Updated May 13, 2025 · NCT04722029From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.